Honors & Achievements

Advancing Assisted Reproductive Technology (ART), Upholding the Right to Fertility

Established in 1987, Lee Women’s Hospital has nearly four decades of experience and has achieved remarkable milestones in the field of reproductive medicine. With the mission of “advancing assisted reproductive technology (ART) and upholding the right to fertility,” we are dedicated to helping individuals and couples achieve their dream of parenthood through comprehensive, effective, and personalized ART service.

Advancing Assisted Reproductive Technology (ART), Upholding the Right to Fertility

Lee Women’s Hospital emphasizes both clinical practice and academic research. We maintain close collaborations with leading universities and research institutions worldwide, continually investing in research and innovation in reproductive medicine.

Each year, our team presents cutting-edge papers at major international conferences such as the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM). To date, we have published over 350 research papers in renowned academic journals, ensuring we remain at the forefront of global reproductive science. Our partnerships extend across Europe, the U.S., Japan, Australia, and beyond. Notably, our 2014 collaboration with National Chiao Tung University on a microfluidic chip for assisted reproduction earned the 2020 National Innovation Award. In 2024, we opened the Banqiao Fertility Center, and by 2026, a large-scale teaching hospital in Zhubei will begin operations—passing on the legacy of Lee Women’s Hospital to benefit future generations.

International-Grade Research and Academic Recognition

With the rapid advancement of ART and the increasing global demand for infertility treatment, Lee Women’s Hospital remains dedicated to international-level research and academic exchange. Our goal is to expand treatment cycles, promote scientific progress, and deliver superior medical care to our patients.

With professionalism and precision, we actively participate in global academic forums, sharing our latest research and maintaining strong ties with top institutions and experts worldwide. Our research spans embryo culture, genetic screening, and optimization of fertility treatments, achieving several breakthrough results that have enhanced our standing in the field and contributed meaningfully to the advancement of ART worldwide.

Major Milestones and Achievements

2024

First Prize, Taiwan Association of Obstetrics and Gynecology: “Significantly shortened telomere length and altered androgen receptor expression in granulosa cells of women with PCOS”
Third Prize in both basic and clinical research categories at the Taiwan Society for Reproductive Medicine Annual Meeting:
“Innovative thawing protocols in donor egg cycles”
“Quantifying single blastocyst respiration using oxygen-sensing chips”

2023

First Prize, Excellent Paper Award at the Taiwan Society for Reproductive Medicine: “Presence of vacuoles in Day 5 blastocysts is negatively associated with euploidy and live birth rate”
Third Prize, Basic Research Oral Presentation, in collaboration with National Chung Hsing University
Research topic: “Rapid assessment of embryonic respiratory activity using microelectrode chip with concentric-step design”
Four studies selected by ASRM (1 oral presentation + 3 posters)

2022

Poster presentation selected by ASRM

2021

Multiple AI-based embryo selection papers published in Frontiers in Genetics

2019

Genetic Diagnosis Laboratory obtained ISO 15189 certification

Excellence in Medical Research
Over 350 Publications in International Medical Journals

Lee Women’s Hospital’s laboratories are staffed with numerous master’s and Ph.D.-level embryologists who combine rich clinical experience with strong academic expertise. Each year, the team presents multiple professional papers at internationally renowned reproductive medicine conferences and journals in Taiwan, Europe, and the United States, showcasing the hospital’s outstanding research achievements in reproductive medicine.

Published Journal Articles List

Collaboration with Leading International Research Institutions

Over the years, Lee Women’s Hospital has actively engaged in cross-national collaborations with numerous prestigious medical institutions across Europe, the United States, Japan, and Australia. In 2014, we partnered with the Institute of Biomedical Engineering at National Chiao Tung University to develop a microfluidic chip for assisted reproduction, a groundbreaking innovation that was honored with the 2020 National Innovation Award.

Honors and Global Recognition

In the highly competitive field of reproductive medicine, Lee Women’s Hospital Reproductive Center has earned international acclaim for its advanced medical technology, rigorous research standards, and outstanding clinical care.

Through continuous innovation and scientific breakthroughs, we have not only achieved remarkable progress in reproductive research but also set new benchmarks in clinical success rates and patient satisfaction.Our team has received multiple international awards and honors, reflecting not only our professional excellence but also our leadership and global influence in reproductive medicine.These recognitions from around the world inspire us to keep advancing and pursuing new frontiers in reproductive technology.